$4.31
-0.09-2.05%
At close: -
$4.10
-0.21-4.87%
After Hours: 5:36 PM EDT
Revelation Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Revelation Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $-13.44 | $-45.44 | 70.4 % |
Q2 | 2024-08-09 | $-82.08 | $-28.80 | -185.0 % |
Q1 | 2024-05-10 | $-39.36 | $-28.32 | -39.0 % |
Q4 | 2024-03-22 | $-133.28 | $-220.32 | 39.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Revelation Biosciences (REVB) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $-13.44, which beat the estimate of $-45.44.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.